Riskpilot← Back to searchSign inGet full accessPac Shinko Pharma AB
ABBankruptOrg 5591219943Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20171 employees
Revenue 2020
SEK 512K
EBITDA margin
-16.2%
Equity ratio
-9.3%
Financial strength
Net profit 2020
SEK -84K
1 employees
| Revenue | SEK 512K | — |
| EBITDA | SEK -83K | — |
| Net profit | SEK -84K | — |
| Total assets | SEK 364K | +628% |
| Equity | SEK -34K | -168% |
| Employees | 1 | — |
Legal name
Pac Shinko Pharma AB
Org number
5591219943
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
18 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet som hyr ut personal. Uppdragen innefattar allt från apoteks arbete, sjukvården samt tjänster i läkemedelsbolag. Bolaget kommer också så småningom äga och förvalta fastigheter och värdepapper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 |
|---|---|---|---|
| Revenue | 0 | 0 | 512 |
| Staff expenses | — | — | — |
| EBITDA | — | — | −83 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 0 | 0 | −83 |
| Net financials | — | — | −1 |
| Profit before tax | 0 | 0 | −84 |
| Tax | −0 | −0 | −0 |
| Net profit | 0 | 0 | −84 |
| Item | 2018 | 2019 | 2020 |
|---|---|---|---|
| Total assets | 50 | 50 | 364 |
| Equity | 50 | 50 | −34 |
| Long-term debt | 0 | 0 | 190 |
| Short-term debt | 0 | 0 | 208 |
| Total debt | — | — | 398 |
EBITDA margin
-16.2%
This company
15.8%
Market median
-203% vs market
20182020
Equity ratio
-9.3%
This company
38.2%
Market median
-124% vs market
20182020
Return on equity
-8400000.0%
This company
18.4%
Market median
-45652274% vs market
20182020
Net profit margin
-16.4%
This company
8.1%
Market median
-302% vs market
20182020
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
20182020
Debt / equity
11.71×
This company
0.62×
Market median
-1789% vs market
20182020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-08-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IA Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (2) | ||
AA Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
RA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pac Shinko Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Abdisalam Abdi Ali | Chief Executive Officer | 0 companies |
| Rahma Ahmed | Deputy Chief Executive Officer | 0 companies |
| Ibrahim Abdiaziz Mohamed | Chief Executive Officer | 0 companies |
| Hafsa Mohamud Farah | Deputy Board Member | 0 companies |
| Dega Hagi Adam Ali | Deputy Board Member | 0 companies |